180 related articles for article (PubMed ID: 33617514)
21. The changing age distribution of prostate cancer in Canada.
Neutel CI; Gao RN; Blood PA; Gaudette LA
Can J Public Health; 2007; 98(1):60-4. PubMed ID: 17278680
[TBL] [Abstract][Full Text] [Related]
22. The impending Canadian prostate cancer epidemic.
Morrison HI; MacNeill IB; Miller D; Levy I; Xie L; Mao Y
Can J Public Health; 1995; 86(4):274-8. PubMed ID: 7497416
[TBL] [Abstract][Full Text] [Related]
23. Prostate Cancer in Lebanon: Incidence, Temporal Trends, and Comparison to Countries From Different Regions in the World.
Lakkis NA; Osman MH
Cancer Control; 2021; 28():10732748211055267. PubMed ID: 34758644
[TBL] [Abstract][Full Text] [Related]
24. Longitudinal trends in prostate cancer incidence, mortality, and survival of patients from two Shanghai city districts: a retrospective population-based cohort study, 2000-2009.
Hu Y; Zhao Q; Rao J; Deng H; Yuan H; Xu B
BMC Public Health; 2014 Apr; 14():356. PubMed ID: 24731197
[TBL] [Abstract][Full Text] [Related]
25. Prostate cancer incidence and mortality trends among elderly and adult Europeans.
Vercelli M; Quaglia A; Marani E; Parodi S
Crit Rev Oncol Hematol; 2000 Aug; 35(2):133-44. PubMed ID: 10936470
[TBL] [Abstract][Full Text] [Related]
26. Trends in prostate cancer incidence, hospital utilization and surgical procedures, Canada, 1981-2000.
Neutel CI; Gao RN; Blood PA; Gaudette LA
Can J Public Health; 2006; 97(3):177-82. PubMed ID: 16827401
[TBL] [Abstract][Full Text] [Related]
27. Identification of significant geographic clustering of polycythemia vera cases in Montreal, Canada.
Le M; Ghazawi FM; Rahme E; Alakel A; Netchiporouk E; Savin E; Zubarev A; Glassman SJ; Sasseville D; Popradi G; Litvinov IV
Cancer; 2019 Nov; 125(22):3953-3959. PubMed ID: 31381139
[TBL] [Abstract][Full Text] [Related]
28. Uveal melanoma incidence trends in Canada: a national comprehensive population-based study.
Ghazawi FM; Darwich R; Le M; Rahme E; Zubarev A; Moreau L; Burnier JV; Sasseville D; Burnier MN; Litvinov IV
Br J Ophthalmol; 2019 Dec; 103(12):1872-1876. PubMed ID: 30819691
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of adult and pediatric Burkitt lymphoma in Canada: sequelae of the HIV epidemic.
Roy SF; Ghazawi FM; Le M; Lagacé F; Roy CF; Rahme E; Savin E; Zubarev A; Sasseville D; Popradi G; Litvinov IV
Curr Oncol; 2020 Apr; 27(2):83-89. PubMed ID: 32489250
[TBL] [Abstract][Full Text] [Related]
30. [Prostate cancer mortality trends in Chile (1955-2019)].
López JF; Fernández MI; Coz F
Rev Med Chil; 2022 Oct; 150(10):1370-1379. PubMed ID: 37358096
[TBL] [Abstract][Full Text] [Related]
31. 1992 Canadian Cancer Statistics.
Illing EM; Gaudette LA; McLaughlin J; McBride M
Health Rep; 1992; 4(2):161-74. PubMed ID: 1421019
[TBL] [Abstract][Full Text] [Related]
32. Incidence trends of conjunctival malignant melanoma in Canada.
Ghazawi FM; Darwich R; Le M; Jfri A; Rahme E; Burnier JV; Sasseville D; Burnier MN; Litvinov IV
Br J Ophthalmol; 2020 Jan; 104(1):23-25. PubMed ID: 31079055
[TBL] [Abstract][Full Text] [Related]
33. Past, Current, and Future Incidence Rates and Burden of Metastatic Prostate Cancer in the United States.
Kelly SP; Anderson WF; Rosenberg PS; Cook MB
Eur Urol Focus; 2018 Jan; 4(1):121-127. PubMed ID: 29162421
[TBL] [Abstract][Full Text] [Related]
34. Does testing for prostate-specific antigen contribute to declining prostate cancer mortality? Estimating the broader economic influences on aggregate prostate cancer mortality rates.
Di Matteo L; Di Matteo R
Eur J Health Econ; 2005 Dec; 6(4):298-308. PubMed ID: 16180027
[TBL] [Abstract][Full Text] [Related]
35. Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences.
Pina F; Castro C; Ferro A; Bento MJ; Lunet N
Eur J Cancer Prev; 2017 Sep; 26(5):404-410. PubMed ID: 27483413
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and Patient Distribution of Oral Cavity and Oropharyngeal SCC in Canada.
Ghazawi FM; Lu J; Savin E; Zubarev A; Chauvin P; Sasseville D; Zeitouni A; Litvinov IV
J Cutan Med Surg; 2020; 24(4):340-349. PubMed ID: 32238063
[TBL] [Abstract][Full Text] [Related]
37. Age-standardized cancer-incidence trends in Canada, 1971-2015.
Brenner DR; Ruan Y; Shaw E; O'Sullivan D; Poirier AE; Heer E; Villeneuve PJ; Walter SD; Friedenreich CM; Smith L; De P
CMAJ; 2019 Nov; 191(46):E1262-E1273. PubMed ID: 31740536
[TBL] [Abstract][Full Text] [Related]
38. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
39. Incidence of differentiated thyroid cancer in Canada by City of residence.
Corsten MJ; Hearn M; McDonald JT; Johnson-Obaseki S
J Otolaryngol Head Neck Surg; 2015 Sep; 44(1):36. PubMed ID: 26374205
[TBL] [Abstract][Full Text] [Related]
40. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
